期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Artificial Intelligence in Pharmaceutical Sciences 被引量:17
1
作者 Mingkun Lu Jiayi Yin +15 位作者 Qi Zhu Gaole Lin Minjie Mou Fuyao Liu Ziqi Pan Nanxin You xichen lian Fengcheng Li Hongning Zhang Lingyan Zheng Wei Zhang Hanyu Zhang Zihao Shen Zhen Gu Honglin Li Feng Zhu 《Engineering》 SCIE EI CAS CSCD 2023年第8期37-69,共33页
Drug discovery and development affects various aspects of human health and dramatically impacts the pharmaceutical market.However,investments in a new drug often go unrewarded due to the long and complex process of dr... Drug discovery and development affects various aspects of human health and dramatically impacts the pharmaceutical market.However,investments in a new drug often go unrewarded due to the long and complex process of drug research and development(R&D).With the advancement of experimental technology and computer hardware,artificial intelligence(AI)has recently emerged as a leading tool in analyzing abundant and high-dimensional data.Explosive growth in the size of biomedical data provides advantages in applying AI in all stages of drug R&D.Driven by big data in biomedicine,AI has led to a revolution in drug R&D,due to its ability to discover new drugs more efficiently and at lower cost.This review begins with a brief overview of common AI models in the field of drug discovery;then,it summarizes and discusses in depth their specific applications in various stages of drug R&D,such as target discovery,drug discovery and design,preclinical research,automated drug synthesis,and influences in the pharmaceutical market.Finally,the major limitations of AI in drug R&D are fully discussed and possible solutions are proposed. 展开更多
关键词 Artificial intelligence Machine learning Deep learning Target identification Target discovery Drug design Drug discovery
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部